Serotonin syndrome following Methylene Blue infusion: a rare complication of antidepressant therapy.
Héritier Barras
Anne-Chantal
AC
Walder
Bernard
B
Seeck
Margitta
M
D000236:Adenoma / Q000175:diagnosis / Q000601:surgery*; D000368:Aged; D000929:Antidepressive Agents, Tricyclic / Q000008:administration & dosage / Q000633:toxicity*; D002997:Clomipramine / Q000008:administration & dosage / Q000633:toxicity*; D003422:Critical Care; D003620:Dantrolene / Q000627:therapeutic use; D004347:Drug Interactions; D004569:Electroencephalography / Q000187:drug effects; D005260:Female; D015600:Glasgow Coma Scale; D006801:Humans; D007262:Infusions, Intravenous; D008751:Methylene Blue / Q000633:toxicity*; D009125:Muscle Relaxants, Central / Q000627:therapeutic use; D009460:Neurologic Examination / Q000187:drug effects; D010282:Parathyroid Neoplasms / Q000175:diagnosis / Q000601:surgery*; D016105:Parathyroidectomy; D011183:Postoperative Complications / Q000139:chemically induced* / Q000175:diagnosis; D020230:Serotonin Syndrome / Q000139:chemically induced* / Q000175:diagnosis / Q000188:drug therapy; D017367:Selective Serotonin Reuptake Inhibitors / Q000008:administration & dosage / Q000633:toxicity*
D000929:Antidepressive Agents, Tricyclic; D002997:Clomipramine; D003620:Dantrolene; D008751:Methylene Blue; D009125:Muscle Relaxants, Central; D017367:Selective Serotonin Reuptake Inhibitors